Market Place
Sourcing Support
PsychoGenics Awarded NIH Contract For Pain Therapeutics
08 Oct 2024 //
BUSINESSWIRE
PsychoGenics Awarded $3M Grant For Rare Disorder Treatments
28 Aug 2024 //
BUSINESSWIRE
PsychoGenics Announces Exclusive Global License for an IND-Ready ENT1 Inhibitor
01 Dec 2023 //
BUSINESSWIRE
PsychoGenics Launches an Updated Corporate Identity and Brand
10 Nov 2023 //
BUSINESSWIRE
PsychoGenics and Collaborations Pharmaceuticals awarded a $1M grant
05 Sep 2023 //
BUSINESSWIRE
PsychoGenics Launches eCube, a New AI-Enabled Platform for Drug Discovery
06 Apr 2023 //
BUSINESSWIRE
PsychoGenics on board for Iama`s Dravet syndrome study
19 Jan 2023 //
FIERCE BIOTECH
IAMA and Psychogenics Sign a Preclinical Study Agreement for Dravet Syndrome
12 Jan 2023 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.